Anti-platelet Aggregation Drug Indobufen CAS 63610-08-2

Basic Info

Model No.:  63610-08-2

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

Indobufen CAS number is 63610-08-2,which is an anti-platelet aggregation drug that acts selectively on circulating platelets, blocks thrombus formation and inhibits platelet factor release and exerts anti-platelet aggregation, which is reversible and does not change Plasma parameters, non-destructive platelet function, and abnormal platelet function returned to normal. It can make patients with peripheral vascular disease and patients with intermittent claudication microcirculation parameters and walking distance significantly improved coronary artery shunt and femoral artery shunt to prevent obstruction in the same aspirin plus dipyridamole effect; hemodialysis, It can significantly reduce platelet deposits on dialysis membranes. The product of Indobufen CAS number 63610-08-2,can also prevent secondary thrombosis after a transient ischemic attack or mild stroke. Compared with similar drugs, indobufen inhibits platelet factor, anti-platelet aggregation effect is salicylic acid 2 to 5 times shorter bleeding time than the slight duration. Compared with ticlopidine, oral clinical efficacy no significant difference, but indobufen showed good tolerability.

Thera. Category:anti-platelet aggregation

Cas No.:  63610-08-2

Synonym: lndobufen;INDOBNFEN;2-[4-(1-oxo-2-isoindolinyl)phenyl]butyric acid

Molecular Weight:  295.33

Molecular formula:C18H17NO3

Assay: ≥98.%

Appearance: White Crystalline solid

Packing:Export worthy packing

Material Safety Data Sheet:Available on request